Elacestrant in Preoperative Setting, a Window of Opportunity Study

NCT04797728 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Hormone Receptor Positive Breast Carcinoma

Interventions

DRUG: Elacestrant

Sponsor

SOLTI Breast Cancer Research Group

Collaborators

[object Object]